What types of agencies buy Cell Therapy services?

Federal agencies across all departments procure Cell Therapy services, including the Department of Defense, Department of Veterans Affairs, General Services Administration, and civilian agencies. State and local governments also issue Cell Therapy contracts through their own procurement portals.

How do I find Cell Therapy contracts with SamSearch?

Use SamSearch to browse pre-classified opportunities in one place, with AI-powered filtering by agency, set-aside, and deadline.

Are there set-aside contracts for small businesses in Cell Therapy?

Yes. Many Cell Therapy contracts are set aside for small businesses, including 8(a), WOSB, SDVOSB, and HUBZone firms. Use SamSearch's set-aside filters to find contracts your business qualifies for.

How competitive are Cell Therapy government contracts?

Competition varies by contract size and type. Large IDIQ vehicles in Cell Therapy can attract dozens of bidders, while small open-market solicitations may have only a few. Monitoring active solicitations and building agency relationships early improves win rates.

Contract Category

Cell Therapy Government Contracts

8 government contract opportunities classified as Cell Therapy, spanning federal and state/local solicitations. Updated daily.

5 federal3 SLEDUpdated daily

Federal Opps

Federal contracts

SLED Opps

State, local & education contracts

Forecasts

—

Agency pipeline forecasts

Total

All sources combined

5 federal contract opportunities classified as Cell Therapy.

DEPARTMENT OF VETERANS AFFAIRS

AN12--STEM CELL THERAPY -WO/WD, BONLY POP 05/18/2026 - 5/17/2027

Active

AI Summary

The Department of Veterans Affairs is seeking sources for stem cell therapy services for the period from May 18, 2026, to May 17, 2027. This opportunity is set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBC). Interested parties should respond to this sources sought notice.

Posted Apr 16, 2026Due May 18, 2026Sources SoughtNAICS 541380Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14)Sol: 36C26226Q0653

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

CYTEK AURORA 3 LASER WITH LOADER

Archived

AI Summary

The National Institutes of Health intends to negotiate a five-year service contract for Cytek Aurora 3 laser flow cytometers. This contract will support clinical research and cell therapeutic product development. Interested vendors may submit capability statements by April 23, 2026, for consideration.

Posted Apr 13, 2026Due Apr 23, 2026Special NoticeNAICS 334516Sol: NOI-OLAO-CC-26-003467

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

NOTICE OF INTENT TO SOLE SOURCE – LEASE OF AVATAR™ ODYSSEY INSTRUMENTS (XCELL BIOSCIENCES)

Archived

AI Summary

The Department of Health and Human Services intends to award a sole source contract to Xcell Biosciences for leasing four Avatar™ Odyssey instruments for six months. These instruments are essential for process development in cell therapy, providing precise control of cellular microenvironment conditions. Interested par…

Posted Apr 1, 2026Due Apr 10, 2026PresolicitationNAICS 532490Sol: 26-004627

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

NOTICE OF INTENT TO SOLE SOURCE – BD BIOSCIENCES

Archived

AI Summary

The Department of Health and Human Services intends to award a sole source contract to BD Biosciences for a five-year service contract involving maintenance of flow cytometers and related equipment. This acquisition is conducted under FAR Part 13 Simplified Acquisition Procedures, allowing for a single-source procureme…

Posted Mar 19, 2026PresolicitationNAICS 811210Sol: NOI-OD-26-003977

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

MAXCYTE EXPERT GTX ELECTROPORATION DEVICE AND INSTALLATION/OPERATIONAL QUALIFICATION (IQ/OQ)

Archived

AI Summary

The National Institutes of Health intends to award a sole source contract for the MaxCyte ExPERT GTx Electroporation Device and associated installation and operational qualification services. This acquisition is necessary to maintain compliance with cGMP standards in cell-based therapy manufacturing. Interested parties…

Posted Mar 6, 2026Due Mar 13, 2026PresolicitationNAICS 541714Sol: 26-003578

View details→